These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4902500)
21. [Ovulen, its effect on the endometrium, uterine cervix and ovary]. Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661 [No Abstract] [Full Text] [Related]
22. [Therapy of juvenile acne in women with the norethinodrel-mestranol combination]. Bellone AG; Aessi E G Ital Dermatol Minerva Dermatol; 1966; 107(1):35-42. PubMed ID: 4224765 [No Abstract] [Full Text] [Related]
23. [Treatment of cervical endometriosis with synthetic progestins]. Kravkova EV; Prokhorova LM; Strizhakov AN Sov Med; 1971 Jan; 34(1):37-9. PubMed ID: 5580237 [No Abstract] [Full Text] [Related]
24. Amelioration of premenstrual mood disturbance with a progestational agent (enovid). Kane FJ; Daly RJ; Wallach MH; Keeler MH Dis Nerv Syst; 1966 May; 27(5):339-42. PubMed ID: 5327469 [No Abstract] [Full Text] [Related]
25. Mood and behavioral changes associated with the use of the oral contraceptive agents. A review of the literature. Glick ID Psychopharmacologia; 1967; 10(5):363-74. PubMed ID: 4871582 [No Abstract] [Full Text] [Related]
26. Enovid therapy (norethynodrel with mestranol) for fibrocystic disease. Ariel IM Am J Obstet Gynecol; 1973 Oct; 117(4):453-9. PubMed ID: 4743352 [No Abstract] [Full Text] [Related]
27. [Therapy of dysmenorrhea]. Cazzola D Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568 [No Abstract] [Full Text] [Related]
30. Norethynodrel-mestranol (enovid) for prevention and treatment of the climacteric. Wilson RA; Marino ER; Wilson TA J Am Geriatr Soc; 1966 Oct; 14(10):967-85. PubMed ID: 5924635 [No Abstract] [Full Text] [Related]
32. Pseudopregnancy. Treatment of periodic psychiatric illness: a pilot study. Glick ID; Hauptman B; Klein DF Psychiatr Q; 1970; 44(3):403-7. PubMed ID: 5514887 [No Abstract] [Full Text] [Related]
33. [Blood coagulation system indices in women with dysfunctional hemorrhage during treatment with infecundin]. Manuilova IA; Aronovich AS; Tumanova AE Sov Med; 1971 Jan; 34(1):27-30. PubMed ID: 5580234 [No Abstract] [Full Text] [Related]
34. The menopause--its meaning and management. Marino ER Trans N Engl Obstet Gynecol Soc; 1964; 18():119-23. PubMed ID: 5832964 [No Abstract] [Full Text] [Related]
35. [Effect of infecundin on glucocorticoid function of the adrenal cortex in patients with dyshormonal hyperplasia of the endometrium]. Rotkina IE Sov Med; 1974 Jun; 37(6):110-4. PubMed ID: 4846344 [No Abstract] [Full Text] [Related]
36. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea. Matthews AE; Clarke JE J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921 [No Abstract] [Full Text] [Related]
37. Oral progestins and regression of carcinoma in situ and cervical dysplasia. A cytologic evaluation. Ayre JE; Reyner FC; Fagundes WB; Leguerrier JM Obstet Gynecol; 1969 Oct; 34(4):545-60. PubMed ID: 5822680 [No Abstract] [Full Text] [Related]
38. [Effect of synthetic progestins on the content of sex chromatin in endometrial hyperplasia]. Rotkina IE; Lutsik LA Akush Ginekol (Mosk); 1977 Jul; (7):33-5. PubMed ID: 900404 [No Abstract] [Full Text] [Related]
39. [Apropos of the treatment of acne with a synthetic estroprogestative agent]. Jamain C; Cattin R Bull Soc Fr Dermatol Syphiligr; 1966; 73(2):161-3. PubMed ID: 4223751 [No Abstract] [Full Text] [Related]